Ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate
C24H27N3O5 — CID 169250519
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate
Ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate (PubChem CID 169250519) has the molecular formula C24H27N3O5 and a molecular weight of 437.50 g/mol. Its IUPAC name is ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate.
Molecular Properties
| Compound Name | Ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate |
|---|---|
| PubChem CID | 169250519 |
| Molecular Formula | C24H27N3O5 |
| Molecular Weight | 437.50 g/mol |
| Exact Mass | 437.20 |
| IUPAC Name | ethyl 5-methoxy-2-[2-[(3R)-3-methoxypyrrolidin-1-yl]quinolin-3-yl]-6-methyl-4-oxo-1H-pyridine-3-carboxylate |
| SMILES | CCOC(=O)c1c(-c2cc3ccccc3nc2N2CC[C@@H](OC)C2)[nH]c(C)c(OC)c1=O |
| InChI | InChI=1S/C24H27N3O5/c1-5-32-24(29)19-20(25-14(2)22(31-4)21(19)28)17-12-15-8-6-7-9-18(15)26-23(17)27-11-10-16(13-27)30-3/h6-9,12,16H,5,10-11,13H2,1-4H3,(H,25,28)/t16-/m1/s1 |
| InChIKey | OHWZJWARRCZWBA-MRXNPFEDSA-N |
| XLogP | 3.31 |
| TPSA | 93.75 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.50 |
| LogP ≤ 5 | 3.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169250519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.